BREAKING
Home » Posts Tagged "antibiotics"

Antibiotic Shows Effectiveness Against Deadly Staph Infections

By

NewsDesk @bactiman63 An antibiotic that has shown effectiveness for bacterial pneumonia also appears successful in fighting methicillin-resistant staph infections, reports a team led by Duke Health. The...

MRSA: University of Bath’s novel compound that both inhibits the superbug in lab experiments and renders it more vulnerable to antibiotics

By

NewsDesk @bactiman63 A compound that both inhibits the MRSA superbug and renders it more vulnerable to antibiotics has been discovered by scientists at the University of Bath led by Dr Maisem Laabei and Dr...

Neisseria

New antibiotics to be developed for multidrug resistant gonorrhea: Griffith University receives grant

By

Researchers from the Institute of Glycomics have been awarded more than $1,100,000 million in National Health and Medical Research Council (NHMRC) grant funding to develop new antibiotics for the treatment...

C. diff awareness

By

By NewsDesk  @bactiman63 November is C. diff awareness month and the Peggy Lillis Foundation is out there leading the charge building awareness by educating the public, empowering advocates, and shaping...

Antibiotics: Cubicin recalled due to presence of glass particles

By

NewsDesk @bactiman63 Merck announced voluntarily recalling one lot of CUBICIN® (daptomycin for injection) 500mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely...

Potential Overuse of Antibiotics Found in Patients with Severe COVID-19 Pneumonia

By

Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse...

Antibiotics: DALVANCE receives FDA approval

By

AbbVie announced Friday that the U.S. Food and Drug Administration (FDA) approved DALVANCE® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric...

Staph

New antibiotic for treating MRSA, KIMYRSA, now commercially available

By

By NewsDesk  @infectiousdiseasenews Morristown, NJ pharmaceutical company, Melinta Therapeutics announced this week that their lipoglycopeptide antibiotic, KIMYRSA™ (oritavancin), is now commercially...

Antibiotic, Solosec, receives FDA approval as treatment of trichomoniasis

By

By NewsDesk  @infectiousdiseasenews Today, the U.S. Food and Drug Administration (FDA) approved Lupin Pharmaceuticals supplemental New Drug Application (sNDA) to expand the use of SOLOSEC® (secnidazole)...

Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study

By

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic...